A case report on the efficacy of a short-term physiotherapy intervention strategy in the initial stages of Multiple Sclerosis
Multiple sclerosis is a chronic autoimmune progressive disease of demyelination of the central nervous system with subsequent axonal damage. The symptoms are due to loss of oligodendrocytes, but CNS diseased effects are often controlled through rehabilitation. The goal of this study is to see if early physiotherapy rehabilitation combined with immunosuppressants can suppress and minimize symptoms while also slowing down the illness process from the first day of hospitalization to six weeks, which normally causes the patient's condition to deteriorate. The patient is required to follow the physiotherapy guidelines for a period of six weeks. Based on their symptoms, the patient's interventions were gradually increased each week. The functional independence measure (FIM) and the Short Form survey-12 were used to assess the patient's everyday quality of life in the first week and then again in the seventh week (SF-12).There is a variation in the value of outcome measures after the 7th re-assessment. The FIM level has risen from 3-moderate assistance with assistance to 6-modified independence without assistance. The SF-12 physical score improved significantly from 48.020307 to 56.57706, whereas the SF-12 mental score changed just slightly. Multiple sclerosis disease impairment is mostly caused by disease progression, but it can also be exacerbated by decreased physical activity, which causes muscle weakness, limited range of motion, and stiffness. Exercise and training have demonstrated improvement of the above-mentioned deteriorations in multiple sclerosis patients
Copyright (c) 2022 Sailaja Nandennagari, Annam Preethi, Annam Reshma, Krupavaram Bethala
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Author(s) shall retain the copyright of their work and grant the Journal/Publisher right for the first publication with the work simultaneously licensed under:
Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows for the copying, distribution and transmission of the work, provided the correct attribution of the original creator is stated. Adaptation and remixing are also permitted.
This broad license intends to facilitate free access to, as well as the unrestricted reuse of, original works of all types for non-commercial purposes.
The author(s) permits HH Publisher to publish this article that has not been submitted elsewhere.